The Discounted Cash Flow (DCF) valuation of Immunome Inc (IMNM) is (145.74) USD. With the latest stock price at 8.84 USD, the upside of Immunome Inc based on DCF is -1748.7%.
Based on the latest price of 8.84 USD and our DCF valuation, Immunome Inc (IMNM) is a sell. selling IMNM stocks now will result in a potential gain of 1748.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.3% | 5.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (792.54) - (82.02) | (145.74) |
| Upside | -9065.3% - -1027.9% | -1748.7% |